Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study
- PMID: 36002209
- PMCID: PMC9413183
- DOI: 10.1136/bmjopen-2021-060361
Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study
Abstract
Objectives: To evaluate the impact of Helicobacter pylori eradication on venous thromboembolism (VTE) events, and the differences between early and late treatment timing.
Design: A population-based cohort study.
Setting: Taiwan's National Health Insurance Research Database.
Participants: A total of 6736 patients who received H. pylori eradication therapy from 2000 to 2010 were identified. We randomly selected 26 944 subjects matching in gender, age and baseline year as comparison cohort.
Primary and secondary outcome measures: The incidence rate ratios of VTE in the H. pylori eradication cohorts to that of the control cohort were examined. Multivariable Cox proportional hazard regression analysis was used to estimate the relative HRs and 95% CI of VTE development.
Results: The total incidence rate of VTE was observed in the late H. pylori eradication cohort, the early H. pylori eradication cohort and the control cohort (15.2, 3.04 and 2.91 per 1000 person-years, respectively). An age-specific trend was found in the late H. pylori eradication cohort, with a greater rate of VTE in the 50-65 years and more than 65 years age groups (adjusted HR 5.44; 95% CI 4.21 to 7.03 and 3.13; 95% CI 2.46 to 3.99). With comorbidities, the late H. pylori eradication cohort seemed to have the highest VTE incidence rate and adjusted HR (4.48, 95% CI 3.78 to 5.30).
Conclusions: Late H. pylori eradication was associated with a significantly increased risk of VTE, and there was a significantly greater risk of VTE in patients with female gender, age more than 50 years and with comorbidities.
Keywords: Adult gastroenterology; Gastrointestinal infections; Thromboembolism.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Impact of Helicobacter pylori eradication on age-specific risk of incident dementia in patients with peptic ulcer disease: a nationwide population-based cohort study.Geroscience. 2025 Feb;47(1):1161-1174. doi: 10.1007/s11357-024-01284-z. Epub 2024 Aug 12. Geroscience. 2025. PMID: 39129052 Free PMC article.
-
Does Helicobacter pylori Eradication Reduce the Risk of Open Angle Glaucoma in Patients With Peptic Ulcer Disease?Medicine (Baltimore). 2015 Sep;94(39):e1578. doi: 10.1097/MD.0000000000001578. Medicine (Baltimore). 2015. PMID: 26426633 Free PMC article.
-
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.Gastroenterology. 2009 Nov;137(5):1641-8.e1-2. doi: 10.1053/j.gastro.2009.07.060. Epub 2009 Aug 5. Gastroenterology. 2009. PMID: 19664631
-
Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials.J Surg Res. 2013 Jun 15;182(2):219-26. doi: 10.1016/j.jss.2012.10.046. Epub 2012 Nov 9. J Surg Res. 2013. PMID: 23158404
-
[The role for Helicobacter pylori infection in intractable and recurrent ulcer].Nihon Rinsho. 1993 Dec;51(12):3221-6. Nihon Rinsho. 1993. PMID: 8283637 Review. Japanese.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical